ArticleSleep medicine: X2025
National trends in mortality associated with obstructive sleep apnea among adults with diabetes mellitus in the United States, 1999-2020.
Article in Sleep medicine: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Uncovering the mortality burden of lung cancer with documented sleep apnea in the United States: a 22-year population-based study.Frontiers in public health · 2026Article
- Rating Scales for Obstructive Sleep Apnea Syndrome: The Importance of a Comprehensive Assessment.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea (OSA) and diabetes mellitus are two prevalent and interrelated chronic conditions that contribute significantly to cardiovascular and metabolic mortality. However, national trends in OSA-related mortality among adults with diabetes remain poorly characterized. Methods: We conducted a cross-sectional analysis of U.S. death certificate data from 1999 to 2020 using the CDC WONDER platform. Adults aged ≥25 years with diabetes mellitus (ICD-10: E10-E14) as the underlying cause of death and OSA (G47.33) as a contributing cause were included. Age-adjusted mortality rates (AAMRs) were calculated per 100,000 population, and temporal trends were assessed using Joinpoint regression. Results: A total of 79,728 deaths were attributed to diabetes and OSA. The overall AAMR was 1.55 (95 % CI: 1.50 to 1.60), increasing significantly from 1999 to 2004 (APC: 19.42 %) and more gradually from 2005 to 2020 (APC: 6.86 %). Males had nearly double the mortality rate of females (2.13 vs. 1.07). The highest AAMRs were observed among American Indian or Alaska Native (2.16) and Black (1.98) individuals. Non-metropolitan areas had higher mortality than metropolitan areas (1.91 vs. 1.48), and the Midwest had the highest regional AAMR (1.95). Crude mortality increased with age, peaking at 5.42 in the 75-84 age group. State-level AAMRs varied nearly sixfold. Most deaths occurred at home (38.5 %), followed by inpatient facilities (32.8 %). Conclusions: Mortality related to OSA in adults with diabetes has risen substantially across all demographics, underscoring the need for targeted interventions in high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.